8. CONFLICT OF INTEREST
All members of the Urolithiasis guidelines working group have provided disclosure statements of all relationships that they have that might be perceived as a potential source of a conflict of interest. This information is provided below and is also publicly available on the EAU website: https://uroweb.org/guidelines/urolithiasis/panel.
This guidelines document was developed with the financial support of the European Association of Urology. No external sources of funding and support have been involved. The EAU is a non-profit organisation, and funding is limited to administrative and travel and meeting expenses. No honoraria or other reimbursements have been provided.
Disclosures: The EAU Guidelines Office certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (e.g., employment/ affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: H.U. Jung reported serving as company consultant for AMBU A/S, AMBU, and receiving company speaker honoraria from Boston Scientific. G. Kamphuis reported serving as a company consultant for Olympus and Boston Scientific, Coloplast Porges and AMBU A/S, AMBU, and Company speaker honorarium from Alnylam Pharmaceuticals. A. Neisius reported receiving honoraria or consultation fees from Boston Scientific Europe and Desitin Arzneimittel GmbH, and receiving company speaker honoraria from Recordati Pharma GmbH, Aristo, Johnson & Johnson, and Merck. A. Petřík reported receiving company speaker honoraria from Olympus Czech Group, S.R.O. and Surgicare. B. Somani reported receiving honoraria or consultation fees from Zhuhai Pusen Medical Technology Co., Ltd., Boston Scientific, CJ Medical, GlaxoSmithKline, Novo Nordisk and Coloplast. T. Tailly reported working as a company consultant for Ambu GmbH, Cook Medical, Stroz Medical AG, BD and Dornier Med Tech GmbH, and receiving company speaker honorarium from Boston Scientific. S. Croghan, F. Esperto, N. Davis, G. Gambaro, R. Geraghty, L. Lardas, R. Lombardo, I. Manolitsis, A. Skolarikos and L. Tzelves have nothing to declare.